Krystal Biotech (KRYS) total debt

Total debt · fiscal 2025
$9.34M

Krystal Biotech (KRYS) carried total debt of $9.34M at the end of fiscal 2025 (December 31, 2025). That is 28.6% higher than the $7.26M of fiscal 2024. Figures as of 18 Nov 2026, 10:48 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$9.34M
Change on fiscal 2024
+28.6%
Highest on record
$9.34Mfiscal 2025
Lowest on record
$7.26Mfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Krystal Biotech total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $9.34M in fiscal 2025 and the lowest $7.26M in fiscal 2024.

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Krystal Biotech total debt, year by year

Krystal Biotech (KRYS) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$9.34M 28.6% up0.0×
2024$7.26M 10.3% down0.0×
2023$8.09M 9.4% down0.0×
2022$8.93M—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Krystal Biotech and comparable companies
CompanyTotal debtFiscal year
Praxis Precision Medicines PRAX$110.00K2025
Twist Bioscience TWST$94.99M2026
Protagonist Therapeutics PTGX$10.32M2025
Krystal Biotech KRYS$9.34M2025
10x Genomics TXG$84.36M2025
HealthEquity HQY$1.00B2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on KRYS

Krystal Biotech, figure by figure

Krystal Biotech (KRYS) overview: price, valuation and scorecardAll health care companies by market value

Krystal Biotech total debt: questions and answers

How much debt does Krystal Biotech have?

Krystal Biotech (KRYS) carried total debt of $9.34M at the end of fiscal 2025 (December 31, 2025). That is 28.6% higher than the $7.26M of fiscal 2024.

What are the highest and lowest total debt figures on record for Krystal Biotech?

Across the 4 fiscal years on record (2022–2025), the highest was $9.34M in fiscal 2025 and the lowest $7.26M in fiscal 2024.

How does Krystal Biotech's debt compare with its equity?

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

How is Krystal Biotech's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Krystal Biotech it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Krystal Biotech (KRYS) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/KRYS/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.